3 results

Simon Harris: The Minister for Health has said his department is developing a national biosimilar policy. Photograph: Dara Mac Donaill

When the rheumatoid arthritis drug Benepali came on the Irish market last year, it was the first to test a new drug pricing agreement between the Gove(...)

Medicine costs: a significant  portion of the €750 million in savings expected under a drug pricing deal between now and mid-2020 may not be delivered. Photograph: Getty

The Government risks losing out on hundreds of millions of euro in savings on its drug bill because of the failure to buy generic alternatives to exp(...)

 Industry sources say the State  lost between €4 million and €5 million by the delay in reducing the price of Pfizer’s  blockbuster arthritis drug  Enbrel. Photograph: Paul Faith/AFP/Getty Images

The introduction of a biosimilar drug into the Irish market will save the Health Service Executive (HSE) millions of euro this year alone. In Septem(...)